At 6:43 am US eastern time today, the Air Force’s mysterious X-37B space plane broke a new spaceflight record, surpassing the 717 days, 20 hours and 42 minutes its predecessor spent in orbit just a couple years prior.
The X-37B, explained: The Air Force is notoriously tightlipped about the X-37B program. The space plane itself, built by Boeing, is 29 feet long and 9.6 feet tall, boasting a wingspan of nearly 15 feet. It's launched vertically aboard a rocket and lands horizontally on a runway. The current X-37B mission is the fifth of its kind (Orbital Test Vehicle 5 - OTV-5) and was launched in September 2017 by a SpaceX Falcon 9 rocket.
Strange Origins: More than 20 years ago, NASA started looking into developing a cheaper form of the reusable space shuttle that could take crew and cargo into orbit—or potentially ferry people across the globe in suborbital flights lasting just a matter of hours. After changing hands from NASA to the military, the X-37B was born as an uncrewed spaceplane capable of spending months or years in orbit. The first mission was launched in 2010.
Spy Applications: The Air Force claims the X-37B program will advance reusable spacecraft technologies and that it runs experiments related to avionics, propulsion, and materials testing. The Secure World Foundation, a space policy nonprofit, ran down the possible scenarios in 2017 and thinks the X-37B is very likely a platform to test out future reconnaissance technologies, especially ones that could “disappear” unpredictably or be placed clandestinely in lower orbits. The report casts doubt on the idea that the X-37B is a weapons platform of some kind—it’s just too expensive and impractical.
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
How Rust went from a side project to the world’s most-loved programming language
For decades, coders wrote critical systems in C and C++. Now they turn to Rust.
Design thinking was supposed to fix the world. Where did it go wrong?
An approach that promised to democratize design may have done the opposite.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.